European Medicines Agency Approves New Biotechnology Treatments in Amsterdam
The European Medicines Agency, headquartered in Amsterdam, has authorized new gene therapies and personalized oncology treatments, reinforcing the Dutch capital’s role in European pharmaceutical regulation and life sciences.